PC
TNDM icon

Paulson & Co’s Tandem Diabetes Care TNDM Stock Holding History

Paulson & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-54,000
Closed -$4.7M – 96
2016
Q1 		$4.7M Buy
+54,000
New +$4.72M 0.03% 70

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Paulson & Co's TNDM Position: Q3 2017 in Review

Paulson & Co sold out of Tandem Diabetes Care (TNDM) in Q3 2017, closing a stake of 50,000 shares — an estimated $400K sold.

Paulson & Co first reported a position in TNDM in Q1 2017 and held it in 2 quarters. The position peaked at $600K in Q1 2017. 46 funds tracked by Wall St. Rank hold TNDM as of Q3 2017.

  • Paulson & Co reported no remaining Tandem Diabetes Care position as of Q3 2017 after selling out during the quarter.
  • Paulson & Co sold 50,000 Tandem Diabetes Care shares in Q3 2017, an estimated $400K.
  • Paulson & Co first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 2 quarters.
  • Paulson & Co's Tandem Diabetes Care position peaked at $600K in Q1 2017.
  • 46 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.